Related Experiment Videos
Changes in plasmatic biochemical parameters during experimental murine paracoccidioidomycosis
L H Meloni-Bruneri1, C Picina, E Burger
1Departamento de Análises Clínicas e Toxicológicas, Faculdade de Ciências Farmacêuticas, Hospital Universitário, Universidade de São Paulo, Brasil.
Summary
Biochemical markers like glucose and triglycerides can indicate the severity of Paracoccidioides brasiliensis infection in mice. Resistant mice showed fewer changes, highlighting their ability to fight the fungal infection.
Area of Science:
- Medical Mycology
- Biochemistry
- Immunology
Background:
- Paracoccidioides brasiliensis is a fungus causing paracoccidioidomycosis.
- Understanding host-pathogen interactions and disease progression is crucial.
- Biochemical markers can reflect the host's response to infection.
Purpose of the Study:
- To evaluate biochemical changes in mice infected with Paracoccidioides brasiliensis.
- To compare the host response in resistant and susceptible mouse strains.
- To determine the utility of biochemical parameters in assessing infection severity.
Main Methods:
- Intraperitoneal infection of A/J (resistant) and B10.A (susceptible) mice with Paracoccidioides brasiliensis Pb 18.
- Measurement of plasma cholesterol, HDL-cholesterol, triglycerides, total proteins, bilirubin, AST, glucose, iron, and TIBC at 15 and 90 days post-infection.
- Comparison of infected groups with control groups.
Main Results:
- Infected mice showed increased triglycerides and total proteins.
- Susceptible B10.A mice exhibited decreased glucose and HDL-cholesterol, and increased AST, bilirubin, and TIBC.
- Both mouse strains showed decreased iron levels.
- Resistant A/J mice displayed fewer significant biochemical alterations compared to susceptible mice.
Conclusions:
- Biochemical parameters serve as valuable indicators of Paracoccidioides brasiliensis infection severity.
- The host's genetic resistance influences the biochemical response to fungal infection.
- Biochemical monitoring can aid in assessing disease progression and recovery.